International experience with the CardioWest total artificial heart as a bridge to heart transplantation

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue SUPPL., 1997, Pages

  Arabia, F A ^a   Copeland, J G ^a   Smith, R G ^a   Sethi, G K ^a   Arzouman, D A ^a   Pavie, A ^a   Duveau, D ^a   Keon, W J ^a   Masters, R ^a   Foy, B ^a   Carrier, M ^a   Dembitsky, W ^a   Long, J ^a   Kormos, R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART; BLEEDING; CARDIOMYOPATHY; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART DILATATION; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 0030813936     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(97)01183-4     Document Type: Article

References (10)

1. Devries WC, Anderson JH, Joyce LD. Clinical use of the total artificial heart. N Engl J Med 1984;310:273-278.
2. Copeland JG, Levinson MM, Smith R. The total artificial heart as a bridge to heart transplantation. A report of two cases. JAMA 1986;256:2991-2995.
3. Copeland JG, Smith RG, Cleavinger MR. Development and clinical use of the total artificial heart: a review of the current status of the CardioWest C-70 TAH (Jarvik-7). In: Lewis T and Graham T, eds. Mechanical circulatory support. London: Edward Arnold, 1995;186-198.
4. Arabia FA, Copeland JG, Larson DF, Smith RG, Cleavinger MR. Circulatory assist devices: applications for ventricular recovery or bridge to transplant. In: Gravlee GP, Davis RF and Utley JR, eds. Cardiopulmonary bypass: principles and practice. Baltimore: Williams and Wilkins, 1993;693-712.
5. Copeland JG, Smith RG, Cleavinger MR, Icenogle TB, Sethi GK, Rosado LJ. Bridge to transplantation indications for Symbion TAH, Symbion AVAD, and Novacor LVAS. In: Akutsu T and Koyanagi H, eds. Artificial heart 3. Tokyo: Springer-Verlag, 1991;303-308.
6. Szefner J, Cabrol C. Control and treatment of hemostasis in patients with a total artificial heart: the experience of La Pitie. In: Pifarre R, ed. Anticoagulation, hemostasis, and blood preservation in cardiovascular surgery. Philadelphia: Hanley and Belfus, 1993;237-264.
7. Joyce LD, Johnson KE, Cabrol BP. Nine year experience with the clinical use of total artificial hearts as cardiac support devices. ASAIO Trans 1991;34:703-707.
8. Copeland JG, Smith RG, Cleavinger MR, Icenogle TB, Sethi GK, Rosado LJ. Bridge to transplantation indications for Symbion TAH, Symbion AVAD, and Novacor LVAS. In: Akutsu T and Koyanagi H, eds. Artificial heart 3. Tokyo: Springer-Verlag 1991;303-308.
9. Copeland JG, Pavie A, Duveau D. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993 to 1995. J Heart Lung Transplant 1996;15:94-99.
10. Arabia FA, Smith RG, Arzouman DA, Sethi GK, Copeland JG. Success rates of long term circulatory assist devices currently used for bridge to heart transplantation. ASAIO J 1996, In Press.